Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.9685
-0.0415 (-4.11%)
Apr 29, 2026, 1:41 PM EDT - Market open
Valion Bio Market Cap
Valion Bio has a market cap or net worth of $2.79 million as of April 29, 2026. Its market cap has increased by 2.85% in one year.
Market Cap
2.79M
Enterprise Value
-3.49M
1-Year Change
2.85%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since November 11, 2021, Valion Bio's market cap has decreased from $48.09M to $2.79M, a decrease of -94.20%. That is a compound annual growth rate of -47.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.91M | -20.63% |
| Dec 31, 2025 | 3.66M | 11.74% |
| Dec 31, 2024 | 3.28M | 24.20% |
| Dec 29, 2023 | 2.64M | -57.38% |
| Dec 30, 2022 | 6.19M | -83.57% |
| Dec 31, 2021 | 37.69M | -21.62% |
| Nov 11, 2021 | 48.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VivoSim Labs | 4.34M |
| Revelation Biosciences | 4.28M |
| 60 Degrees Pharmaceuticals | 4.27M |
| AIM ImmunoTech | 4.20M |
| Alzamend Neuro | 4.11M |
| Galmed Pharmaceuticals | 4.11M |
| Jaguar Health | 3.93M |
| Matinas BioPharma Holdings | 3.91M |